IMUNON INC. - COMMON
1.0100
07-十月-24 15:59:45
15 分钟延时
股票
-0.0700
-6.48%
今日范围
1.0100 - 1.0700
ISIN
N/A
来源
NASDAQ
-
IMUNON Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
07 10月 2024 08:05:00 条件 Nasdaq GlobeNewswire
-
09 9月 2024 16:06:00 条件 Nasdaq GlobeNewswire
-
09 9月 2024 08:30:00 条件 Nasdaq GlobeNewswire
-
IMUNON to Host R&D Day on September 18th
28 8月 2024 08:30:00 条件 Nasdaq GlobeNewswire
-
IMUNON Reports Second Quarter 2024 Financial Results and Provides a Business Update
14 8月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
07 8月 2024 17:04:00 条件 Nasdaq GlobeNewswire
-
IMUNON Announces $10 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
31 7月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
30 7月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
29 7月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
IMUNON Announces Database Lock for Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian Cancer
24 6月 2024 08:30:00 条件 Nasdaq GlobeNewswire
-
First Participants Vaccinated in IMUNON’s IMNN-101 Phase 1 Clinical Trial
05 6月 2024 08:30:00 条件 Nasdaq GlobeNewswire
-
15 5月 2024 08:30:00 条件 Nasdaq GlobeNewswire
-
IMUNON Announces Site Activation for IMNN-101 Phase 1 Vaccine Study
13 5月 2024 09:00:00 条件 Nasdaq GlobeNewswire
-
IMUNON Reports First Quarter 2024 Financial Results and Provides Business Update
13 5月 2024 08:00:01 条件 Nasdaq GlobeNewswire
-
IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO
08 5月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
06 5月 2024 11:00:00 条件 Nasdaq GlobeNewswire
-
IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101
18 4月 2024 08:30:00 条件 Nasdaq GlobeNewswire
-
IMUNON Reports Compliance with Nasdaq Listing Requirements
11 4月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
IMUNON Reports 2023 Financial Results and Provides Business Update
28 3月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
IMUNON Receives $1.3 Million from Sale of its New Jersey Net Operating Losses
25 3月 2024 08:30:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >